Heading to the #AACR26 Education Session "Small Patients, Big Data: Making Precision Medicine Work in Pediatric Cancer"? Take a look at this study coauthored by speaker David Ziegler. https://t.co/hiB0VdKbQq @ProfDavidZieg
Delighted to share our manuscript - the first look at the epi-transcriptome in DMG!
We discovered that RNA methylation is a critical regulator in DMG. https://t.co/HESeQy3wDx
Delighted to share our manuscript - the first look at the epi-transcriptome in DMG!
We discovered that RNA methylation is a critical regulator in DMG. https://t.co/HESeQy3wDx
Our lab just published a JoVE video article covering PDX models for paediatric brain cancer. Here’s a quick preview!
Link to full video and article: https://t.co/DTdpi0FRYI
Inhibitors of the proteins FACT and BET disrupt transcription in #DiffuseMidlineGlioma and extend survival in mice, hinting this combo can suppress hard-to-target epigenetic drivers of this pediatric cancer. @holly_holliday_@ProfDavidZieg@KidsCancerInst https://t.co/7PgU2zkjvV
Congrats to the team for our work - on the cover of Science Translational Medicine! One more step forward to find effective treatments for #DIPG. Thanks to all our funders - See details here:
Congrats to the team for our work - on the cover of Science Translational Medicine! One more step forward to find effective treatments for #DIPG. Thanks to all our funders - See details here:
New in @ScienceTM 🧬 On the cover!
Our work on diffuse midline glioma (#DMG#DIPG), an incurable paediatric brain cancer driven by epigenetic changes. We asked: Can targeting chromatin slow tumour growth?🔗https://t.co/2PDsWEHna5
#ScienceTranslationalMedicineResearch
New in @ScienceTM 🧬 On the cover!
Our work on diffuse midline glioma (#DMG#DIPG), an incurable paediatric brain cancer driven by epigenetic changes. We asked: Can targeting chromatin slow tumour growth?🔗https://t.co/2PDsWEHna5
#ScienceTranslationalMedicineResearch
Together, these results support dual FACT + BET inhibition as a promising DMG therapy, hitting both tumour-intrinsic vulnerabilities and immune defenses.
@KidsCancerInst@UNSW
Huge thanks to @aaminahkhan_1, @ProfDavidZieg, @maria_tsoli & all collaborators!
Registration and abstract submissions now open for ISPNO 2026! https://t.co/EMrifxcvdF
The world's entire paediatric brain tumour community will be heading Down Under in 2026 - don't miss out!
Join us in Sydney for ISPNO 2026! Experience one of the world’s most vibrant cities, where golden beaches, iconic landmarks & rich First Nations culture await. 🌊🌿
📍 Watch: https://t.co/Po2ZlKBLMm
Registrations open: https://t.co/EMrifxbXo7
#ISPNO2026#Sydney#SeeAustralia